These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 20211299)

  • 1. Variations in prevalent cardiovascular disease and future risk by metabolic syndrome classification in the REasons for Geographic and Racial Differences in Stroke (REGARDS) study.
    Brown TM; Voeks JH; Bittner V; Safford MM
    Am Heart J; 2010 Mar; 159(3):385-91. PubMed ID: 20211299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of 4 different definitions used for the assessment of the prevalence of the Metabolic Syndrome in primary healthcare: The German Metabolic and Cardiovascular Risk Project (GEMCAS).
    Moebus S; Hanisch JU; Aidelsburger P; Bramlage P; Wasem J; Jöckel KH
    Cardiovasc Diabetol; 2007 Sep; 6():22. PubMed ID: 17822558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease: a population-based study.
    Jeppesen J; Hansen TW; Rasmussen S; Ibsen H; Torp-Pedersen C; Madsbad S
    J Am Coll Cardiol; 2007 May; 49(21):2112-9. PubMed ID: 17531661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic syndrome: do clinical criteria identify similar individuals among overweight premenopausal women?
    Alhassan S; Kiazand A; Balise RR; King AC; Reaven GM; Gardner CD
    Metabolism; 2008 Jan; 57(1):49-56. PubMed ID: 18078858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does prevalence of the metabolic syndrome in women with coronary artery disease differ by the ATP III and IDF criteria?
    Brown TM; Vaidya D; Rogers WJ; Waters DD; Howard BV; Tardif JC; Bittner V
    J Womens Health (Larchmt); 2008 Jun; 17(5):841-7. PubMed ID: 18537485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diversity of metabolic syndrome criteria in association with cardiovascular diseases--a family medicine-based investigation.
    Ivezić-Lalić D; Bergman Marković B; Kranjčević K; Kern J; Vrdoljak D; Vučak J
    Med Sci Monit; 2013 Jul; 19():571-8. PubMed ID: 23852333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of the metabolic syndrome and its relation to cardiovascular disease in an elderly Chinese population.
    He Y; Jiang B; Wang J; Feng K; Chang Q; Fan L; Li X; Hu FB
    J Am Coll Cardiol; 2006 Apr; 47(8):1588-94. PubMed ID: 16630995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of metabolic syndrome and its components on cardiovascular disease event rates in 4900 patients with type 2 diabetes assigned to placebo in the FIELD randomised trial.
    Scott R; Donoghoe M; Watts GF; O'Brien R; Pardy C; Taskinen MR; Davis TM; Colman PG; Manning P; Fulcher G; Keech AC;
    Cardiovasc Diabetol; 2011 Nov; 10():102. PubMed ID: 22104275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of different metabolic syndrome definitions and risks of incident cardiovascular events in the elderly.
    Vinluan CM; Zreikat HH; Levy JR; Cheang KI
    Metabolism; 2012 Mar; 61(3):302-9. PubMed ID: 21840552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of vascular disease in metabolic syndrome using three proposed definitions.
    Athyros VG; Ganotakis ES; Elisaf MS; Liberopoulos EN; Goudevenos IA; Karagiannis A;
    Int J Cardiol; 2007 Apr; 117(2):204-10. PubMed ID: 16854482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential of four definitions of metabolic syndrome to discriminate individuals with different 10-year cardiovascular disease risk scores: a cross-sectional analysis of an Iranian cohort.
    Zibaeenezhad MJ; Sayadi M; Karimi-Akhormeh A; Ardekani A; Parsa N; Razeghian-Jahromi I
    BMJ Open; 2022 Feb; 12(2):e058333. PubMed ID: 35168988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of insulin resistance on risk of type 2 diabetes and cardiovascular disease in people with metabolic syndrome.
    Meigs JB; Rutter MK; Sullivan LM; Fox CS; D'Agostino RB; Wilson PW
    Diabetes Care; 2007 May; 30(5):1219-25. PubMed ID: 17259468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of metabolic syndrome by the Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions and their association with coronary heart disease in an elderly Iranian population.
    Hadaegh F; Zabetian A; Tohidi M; Ghasemi A; Sheikholeslami F; Azizi F
    Ann Acad Med Singap; 2009 Feb; 38(2):142-9. PubMed ID: 19271043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of coronary heart disease risk assessments among individuals with metabolic syndrome using three diagnostic definitions: a cross-sectional study from China.
    Zhou J; Gao Q; Wang J; Zhang M; Ma J; Wang C; Chen H; Peng X; Hao L
    BMJ Open; 2018 Oct; 8(10):e022974. PubMed ID: 30366915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adult Treatment Panel III 2001 but not International Diabetes Federation 2005 criteria of the metabolic syndrome predict clinical cardiovascular events in subjects who underwent coronary angiography.
    Saely CH; Koch L; Schmid F; Marte T; Aczel S; Langer P; Hoefle G; Drexel H
    Diabetes Care; 2006 Apr; 29(4):901-7. PubMed ID: 16567835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Black women with polycystic ovary syndrome (PCOS) have increased risk for metabolic syndrome and cardiovascular disease compared with white women with PCOS [corrected].
    Hillman JK; Johnson LN; Limaye M; Feldman RA; Sammel M; Dokras A
    Fertil Steril; 2014 Feb; 101(2):530-5. PubMed ID: 24382375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of metabolic syndrome in Japanese-Brazilians according to specific definitions for ethnicity.
    Xavier NP; Chaim RC; Gimeno SG; Ferreira SR; Hirai AT; Padovani CR; Okoshi MP; Okoshi K
    Metab Syndr Relat Disord; 2010 Apr; 8(2):143-8. PubMed ID: 19900161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic syndrome and the risk of cardiovascular disease in older adults.
    Butler J; Rodondi N; Zhu Y; Figaro K; Fazio S; Vaughan DE; Satterfield S; Newman AB; Goodpaster B; Bauer DC; Holvoet P; Harris TB; de Rekeneire N; Rubin S; Ding J; Kritchevsky SB;
    J Am Coll Cardiol; 2006 Apr; 47(8):1595-602. PubMed ID: 16630996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population-Attributable Risk for Cardiovascular Disease Associated With Hypertension in Black Adults.
    Clark D; Colantonio LD; Min YI; Hall ME; Zhao H; Mentz RJ; Shimbo D; Ogedegbe G; Howard G; Levitan EB; Jones DW; Correa A; Muntner P
    JAMA Cardiol; 2019 Dec; 4(12):1194-1202. PubMed ID: 31642869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A gender-stratified comparative analysis of various definitions of metabolic syndrome and cardiovascular risk in a multiethnic U.S. population.
    Hari P; Nerusu K; Veeranna V; Sudhakar R; Zalawadiya S; Ramesh K; Afonso L
    Metab Syndr Relat Disord; 2012 Feb; 10(1):47-55. PubMed ID: 21999397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.